Ideaya Biosciences Correlations
IDYA Stock | USD 20.75 0.10 0.48% |
The current 90-days correlation between Ideaya Biosciences and MeiraGTx Holdings PLC is 0.39 (i.e., Weak diversification). The correlation of Ideaya Biosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Ideaya Biosciences Correlation With Market
Good diversification
The correlation between Ideaya Biosciences and DJI is -0.01 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ideaya Biosciences and DJI in the same portfolio, assuming nothing else is changed.
Ideaya |
Moving together with Ideaya Stock
0.81 | ILMN | Illumina | PairCorr |
0.84 | INZY | Inozyme Pharma | PairCorr |
0.62 | KURA | Kura Oncology | PairCorr |
0.88 | ABOS | Acumen Pharmaceuticals | PairCorr |
0.85 | ADTX | Aditxt Inc | PairCorr |
0.78 | STRO | Sutro Biopharma | PairCorr |
0.85 | TCRX | Tscan Therapeutics | PairCorr |
0.91 | TERN | Terns Pharmaceuticals | PairCorr |
0.92 | CRNX | Crinetics Pharmaceuticals | PairCorr |
0.85 | CTMX | CytomX Therapeutics | PairCorr |
0.78 | DAWN | Day One Biopharmaceu | PairCorr |
Moving against Ideaya Stock
0.8 | PHGE | Biomx Inc | PairCorr |
0.66 | OPT | Opthea | PairCorr |
0.66 | GANX | Gain Therapeutics | PairCorr |
0.56 | LTRN | Lantern Pharma | PairCorr |
0.52 | CUE | Cue Biopharma | PairCorr |
0.43 | FENC | Fennec Pharmaceuticals | PairCorr |
0.42 | PFE | Pfizer Inc Aggressive Push | PairCorr |
0.64 | DBVT | DBV Technologies Earnings Call This Week | PairCorr |
0.42 | CGTX | Cognition Therapeutics | PairCorr |
0.33 | CPRX | Catalyst Pharmaceuticals | PairCorr |
0.81 | OBI | Ondine Biomedical | PairCorr |
0.79 | EC | Ecopetrol SA ADR | PairCorr |
0.74 | SSNLF | Samsung Electronics | PairCorr |
0.74 | GPI | Group 1 Automotive | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Ideaya Stock performing well and Ideaya Biosciences Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ideaya Biosciences' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
ANAB | 4.83 | 0.05 | 0.01 | 0.02 | 7.08 | 9.45 | 42.28 | |||
MGTX | 2.60 | 0.35 | 0.10 | (3.12) | 3.08 | 5.56 | 15.50 | |||
KROS | 4.17 | (1.44) | 0.00 | (2.73) | 0.00 | 5.53 | 82.94 | |||
FIXX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
VTYX | 4.52 | (0.04) | 0.00 | (0.05) | 0.00 | 11.35 | 35.02 | |||
PTGX | 2.25 | (0.06) | 0.00 | (0.06) | 0.00 | 3.48 | 18.65 | |||
VRNA | 2.55 | 0.82 | 0.31 | (59.62) | 2.17 | 5.87 | 17.34 | |||
SNDX | 2.27 | 0.02 | 0.01 | 0.03 | 2.89 | 5.59 | 12.74 | |||
CERE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
RNA | 2.50 | (0.53) | 0.00 | (0.52) | 0.00 | 4.35 | 13.02 |
Ideaya Biosciences Corporate Management
Mick OQuigley | Chief Development | Profile | |
Stu Dorman | Chief Officer | Profile | |
Paul Stone | CFO VP | Profile | |
JD Esq | Chief Secretary | Profile | |
Matthew MD | VP Oncology | Profile | |
Esq JD | Gen VP | Profile | |
Stuart Dorman | Chief Officer | Profile |